EyePoint (EYPT) Phase 2 PAVIA Trial of DURAVYU in Non-Proliferative Diabetic Retinopathy Did Not Meet its Primary Endpoint

Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/EyePoint+%28EYPT%29+Phase+2+PAVIA+Trial+of+DURAVYU+in+Non-Proliferative+Diabetic+Retinopathy+Did+Not+Meet+its+Primary+Endpoint/23175159.html for the full story.